Key Highlights

  • Solesence rose 33.1% to USD 1.2099 in Friday trading on November 13, 2026, per market data, which suggests a prior close near USD 0.91 (calculated). No corporate release accounting for the move turned up.
  • Revenue in the second quarter of 2026 came to USD 15.3 million, against USD 20.4 million earlier, according to published coverage of the August 19, 2026 report. That is a decline of about 25% (calculated).
  • A market data page refreshed October 23, 2026 gave trailing twelve month sales of USD 55.37 million, a 14.0% drop, alongside a USD 2.91 million trailing net loss.
  • At USD 0.8005 on October 23, 2026, the company had about 70.65 million shares outstanding and a Market Value of roughly USD 56.55 million; today's price implies near USD 85 million (calculated).

A 33.1% Gain Without a Disclosed Announcement

Solesence (NASDAQ:SLSN) advanced 33.1% to USD 1.2099 on Friday, November 13, 2026, per market data. Searches surfaced no company announcement covering the advance between November 11 and 13. A market data page had flagged November 10, 2026 as the anticipated timing for the next report, yet no third-quarter 2026 release has been located, so it is unclear whether results are out. The company, once known as Nanophase Technologies, makes surface-engineered zinc oxide and titanium dioxide ingredients as well as mineral-based UV protection products. Headquartered in Romeoville, Illinois, it took its current name in March 2025. The stock has been erratic, falling 6.54% on October 23, 2026 alone.

Second Quarter Sales Dip Tied to Launch Timing

Solesence (NASDAQ:SLSN) reported second quarter 2026 figures on August 19, 2026. Published coverage placed Revenue at USD 15.3 million, compared with USD 20.4 million a year before, and a summary of the Earnings Call linked the decline to product launch timing while gross Margin held steady. A separate report called earnings roughly break-even, with heavy operating costs weighing. On a market data page refreshed October 23, 2026, trailing twelve month revenue sat at USD 55.37 million, a 14.0% decline, and the trailing net loss at USD 2.91 million. No full-year guidance figures were located, so the quote has no company target to be measured against.

Late Filings, Market Value and Thin Trading Risk

Solesence (NASDAQ:SLSN) filed notice of a late Quarterly Report on August 14, 2026 and submitted the report on August 19. Annual reporting came on March 31, 2026, and an amendment followed on April 23. On October 23 the shares were USD 0.8005, which put market value near USD 56.55 million across 70.65 million shares; at USD 1.2099 the implied figure is roughly USD 85 million (calculated). Key risks are launch timing, ingredient Demand and sparse trading, in which a few orders can shift the quote, spreads can widen and gains can unwind.

Where Things Stand

Nothing confirmed accounts for the 33.1% increase. Solesence (NASDAQ:SLSN) trades at USD 1.2099, against roughly USD 0.80 on October 23, 2026, even though the latest verified results show shrinking sales and a small loss. Next signposts are the third-quarter filing and any release that explains the jump. Until then, treat the move as a price quote on a thinly disclosed small cap rather than proof of improved fundamentals. That 33.1% reading reflects only the live session, and the screener's prior close may be unreliable for a stock this small.